Reply to Letter to the Editor by Thompson et al.

Author:

Chan Yi-Hsin1234ORCID,See Lai-Chu567ORCID,Chao Tze-Fan89ORCID

Affiliation:

1. The Cardiovascular Department, Chang Gung Memorial Hospital at Linkou , Taoyuan City , Taiwan

2. College of Medicine, Chang Gung University , Taoyuan City , Taiwan

3. School of Traditional Chinese Medicine, College of Medicine, Chang-Gung University , Taoyuan City , Taiwan

4. Microscopy Core Laboratory, Chang Gung Memorial Hospital at Linkou , Taoyuan City , Taiwan

5. Department of Public Health, College of Medicine, Chang Gung University , Taoyuan City 33302 , Taiwan

6. Biostatistics Core Laboratory, Molecular Medicine Research Center, Chang Gung University , Taoyuan City 33302 , Taiwan

7. Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou , Taoyuan City 33305 , Taiwan

8. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital , Taipei , Taiwan

9. Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University , Taipei , Taiwan

Publisher

Oxford University Press (OUP)

Reference6 articles.

1. Letter to the editor in response to Chan et al. 2023;Thompson;EHJCVP,2024

2. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study;Chan;Eur Heart J Cardiovasc Pharmacother,2023

3. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry;Romiti;EClinMed,2023

4. Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation;Chan;Heart Rhythm,2020

5. Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies;Chan;Europace,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3